HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1628
https://www.valueinhealthjournal.com/article/S1098-3015(22)03833-5/fulltext
Section Title :
Section Order : 11177
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03833-5&doi=10.1016/j.jval.2022.09.1628
HEOR Topics :
Tags :
Regions :